JPS52148060A - 17 betaaester of testosterone and alphaa dihydrotestosterone - Google Patents

17 betaaester of testosterone and alphaa dihydrotestosterone

Info

Publication number
JPS52148060A
JPS52148060A JP6170477A JP6170477A JPS52148060A JP S52148060 A JPS52148060 A JP S52148060A JP 6170477 A JP6170477 A JP 6170477A JP 6170477 A JP6170477 A JP 6170477A JP S52148060 A JPS52148060 A JP S52148060A
Authority
JP
Japan
Prior art keywords
betaaester
alphaa
dihydrotestosterone
testosterone
alphaa dihydrotestosterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6170477A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6145637B2 (fr
Inventor
Fuan Deru Fuiisu Yohanesu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/691,103 external-priority patent/US4098802A/en
Application filed by Akzo NV filed Critical Akzo NV
Publication of JPS52148060A publication Critical patent/JPS52148060A/ja
Publication of JPS6145637B2 publication Critical patent/JPS6145637B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP6170477A 1976-05-28 1977-05-25 17 betaaester of testosterone and alphaa dihydrotestosterone Granted JPS52148060A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/691,103 US4098802A (en) 1975-02-18 1976-05-28 Oral pharmaceutical preparation having androgenic activity

Publications (2)

Publication Number Publication Date
JPS52148060A true JPS52148060A (en) 1977-12-08
JPS6145637B2 JPS6145637B2 (fr) 1986-10-08

Family

ID=24775172

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6170477A Granted JPS52148060A (en) 1976-05-28 1977-05-25 17 betaaester of testosterone and alphaa dihydrotestosterone

Country Status (12)

Country Link
JP (1) JPS52148060A (fr)
AR (1) AR214323A1 (fr)
BE (1) BE855163A (fr)
CH (1) CH627761A5 (fr)
DE (1) DE2723876C2 (fr)
DK (1) DK146096C (fr)
ES (1) ES459230A1 (fr)
FI (1) FI57597C (fr)
FR (1) FR2352832A1 (fr)
GB (1) GB1567515A (fr)
NL (1) NL7705790A (fr)
SE (1) SE425493B (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011519846A (ja) * 2008-04-28 2011-07-14 ダイアーナル リミテッド 脂質組成物
JP2016514706A (ja) * 2013-03-15 2016-05-23 リポカイン インコーポレーテッド 経口送達用リポバランス長鎖テストステロンエステル
US9943527B2 (en) 2010-11-30 2018-04-17 Lipocine Inc. High-strength testosterone undecanoate compositions
US10561615B2 (en) 2010-12-10 2020-02-18 Lipocine Inc. Testosterone undecanoate compositions
US11433083B2 (en) 2010-11-30 2022-09-06 Lipocine Inc. High-strength testosterone undecanoate compositions
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2253423T3 (es) * 2000-08-23 2006-06-01 Akzo Nobel N.V. Formulacion de un ester de testosterona para uso humano.
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011519846A (ja) * 2008-04-28 2011-07-14 ダイアーナル リミテッド 脂質組成物
US9012436B2 (en) 2008-04-28 2015-04-21 Diurnal Limited Lipid composition
US10973833B2 (en) 2010-11-30 2021-04-13 Lipocine Inc. High-strength testosterone undecanoate compositions
US9943527B2 (en) 2010-11-30 2018-04-17 Lipocine Inc. High-strength testosterone undecanoate compositions
US9949985B2 (en) 2010-11-30 2018-04-24 Lipocine Inc. High-strength testosterone undecanoate compositions
US10226473B2 (en) 2010-11-30 2019-03-12 Lipocine Inc. High-strength testosterone undecanoate compositions
US10799513B2 (en) 2010-11-30 2020-10-13 Lipocine Inc. High-strength testosterone undecanoate compositions
US10881671B2 (en) 2010-11-30 2021-01-05 Lipocine Inc. High-strength testosterone undecanoate compositions
US11311555B2 (en) 2010-11-30 2022-04-26 Lipocine Inc. High-strength testosterone undecanoate compositions
US11364250B2 (en) 2010-11-30 2022-06-21 Lipocine Inc. High-strength testosterone undecanoate compositions
US11364249B2 (en) 2010-11-30 2022-06-21 Lipocine Inc. High-strength testosterone undecanoate compositions
US11433083B2 (en) 2010-11-30 2022-09-06 Lipocine Inc. High-strength testosterone undecanoate compositions
US10561615B2 (en) 2010-12-10 2020-02-18 Lipocine Inc. Testosterone undecanoate compositions
JP2016514706A (ja) * 2013-03-15 2016-05-23 リポカイン インコーポレーテッド 経口送達用リポバランス長鎖テストステロンエステル
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Also Published As

Publication number Publication date
DE2723876A1 (de) 1977-12-15
SE425493B (sv) 1982-10-04
GB1567515A (en) 1980-05-14
JPS6145637B2 (fr) 1986-10-08
AR214323A1 (es) 1979-05-31
FI57597C (fi) 1980-09-10
DK236877A (da) 1977-11-29
FI57597B (fi) 1980-05-30
CH627761A5 (en) 1982-01-29
DE2723876C2 (de) 1986-10-30
NL7705790A (nl) 1977-11-30
DK146096B (da) 1983-06-27
SE7706235L (sv) 1977-11-29
ES459230A1 (es) 1978-11-16
BE855163A (fr) 1977-11-28
FR2352832B1 (fr) 1980-07-11
DK146096C (da) 1983-11-21
FR2352832A1 (fr) 1977-12-23
FI771684A (fr) 1977-11-29

Similar Documents

Publication Publication Date Title
JPS5289649A (en) Compositions and process
JPS5395989A (en) Substituted 11thienyl and furyll 2*3*4*55tetrahydroo1hh33benzazepine compound
JPS52100446A (en) Compositions and process
JPS5293535A (en) Haymaker having functions of mowering and drying
JPS53141292A (en) Novel imidazoazine and * imidazodiazine
ZA772084B (en) Testosterone 5a-reductase inhibitors
JPS51131880A (en) 11*3*3*33triarylpropyl**44 phenyll44piperidinemethanol and analogous compounds
GB1539021A (en) Arrangements and devices for facilitating the movement of luggage
JPS5289650A (en) Compositions and process
JPS52148060A (en) 17 betaaester of testosterone and alphaa dihydrotestosterone
JPS52139040A (en) 22 and 33substituted enekephlin
JPS5289648A (en) Compositions and process
JPS54106462A (en) 33*nnacyllnnarylamino**gammaabutyrolactone and gammaabutyrothiolactone
JPS52153975A (en) Dihydroo and tetrahydroo iminothazidine
JPS52133954A (en) Compositions and process
JPS53132582A (en) 33*11piperadinyl**1*2*44benzotriazine and nnoxide
JPS52133995A (en) 1*2*44thiadiazinone and its preparation and application thereof
JPS527966A (en) 99hydroxyy7*8*9*100tetrahydroo 6hhdibenzo*b**d*bilanes and bilanones
PH13879A (en) D-homo steroid and composition containing the same
JPS5365853A (en) 15 * 166dihydroxyprostaglandin and like
JPS52108979A (en) 33substitutedd55phenyll55pyridylhydantoin and antiiarrhythmic agents
JPS52100449A (en) Compositions and process
JPS52103324A (en) Compound material of antiiabrasion and shockkresisting
PH14030A (en) Derivatives of 2-iminothiazolidine and 2-iminothiazoline
JPS52128353A (en) Process and compositions